- Bevorzugter Name
- Lissoclinamide 5
- IUPAC
- (2S,8S,15R,22S,25S,26R)-8,15-Dibenzyl-26-methyl-22-(propan-2-yl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1~11,14~.1~18,21~.0~2,6~]triaconta-1(28),11,14(30),18,21(29)-pentaene-7,10,17,24-tetrone
- Englischer Name
- (7R,14S)-14-Demethyl-7-de(1-methylpropyl)-14-phenylmethyl-7-(1-methylethyl)ulicyclamide
- Summenformel
- C38H41N7O5S2
- Molmasse
- 739.91
Namen und Synonyme
Lissoclinamide 5(7R,14S)-14-Demethyl-7-de(1-methylpropyl)-14-phenylmethyl-7-(1-methylethyl)ulicyclamide3H,12H-4,1:11,8:18,15-Trinitrilo-1H-pyrrolo[2,1-c][1,11,18,4,7,14,21]oxadithiatetraazacyclotetracosine-5,12,19,22(4H)-tetrone, 6,7,13,14,20,21,24,25,26,26a-decahydro-3-methyl-7-(1-methylethyl)-14,21-bis(phenylmethyl)-, (3R,4S,7S,14R,21S,26aS)-
Datenbank-Bezeichner
- PubChem CID
- 179978
- DTXSID
DTXSID90153039- Nikkaji
- J1.288.203C